Public deck

Advanced Biomed: The No-Revenue Biotech That Just Swerved Into AI

Advanced Biomed has historical cancer-diagnostics technology, but the latest filings show no product revenue, a reverse split, a short-term loan, a subsidiary divestiture, and an April 2026 pivot into AI.